A leading automation company powering life sciences labs, has raised $40m to accelerate its rapid growth and industry presence across the US, UK and EMEA.
FDA offers clarity on post-warning letter meetings in new draft guidance
FDA on Friday published draft guidance laying out its approach to post-warning letter meetings for generic drugmakers, including the criteria for granting the meetings and